Table of Content

1 INTRODUCTION 45
1.1 STUDY OBJECTIVES 45
1.2 MARKET DEFINITION 45
1.3 STUDY SCOPE 45
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 46
1.3.2 YEARS CONSIDERED 47
1.3.3 INCLUSIONS AND EXCLUSIONS 47
1.4 CURRENCY CONSIDERED 48
1.5 UNIT CONSIDERED 48
1.6 STAKEHOLDERS 48
1.7 SUMMARY OF CHANGES 49
2 RESEARCH METHODOLOGY 50
2.1 RESEARCH DATA 50
2.1.1 SECONDARY DATA 51
2.1.2 PRIMARY DATA 51
2.2 MARKET SIZE ESTIMATION METHODOLOGY 53
2.2.1 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE ESTIMATION 53
2.2.2 INSIGHTS FROM PRIMARY EXPERTS 56
2.2.3 TOP-DOWN APPROACH 56
2.3 MARKET GROWTH RATE PROJECTIONS 57
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 59
2.5 RESEARCH ASSUMPTIONS 60
2.6 RISK ANALYSIS 61
2.7 RESEARCH LIMITATIONS 61
3 EXECUTIVE SUMMARY 62
4 PREMIUM INSIGHTS 66
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN SINGLE-CELL ANALYSIS MARKET 66
4.2 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE AND COUNTRY 67
4.3 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT 67
4.4 SINGLE-CELL ANALYSIS MARKET, BY END USER 68
4.5 SINGLE-CELL ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 68
5 MARKET OVERVIEW 69
5.1 INTRODUCTION 69
5.2 MARKET DYNAMICS 69
5.2.1 DRIVERS 71
5.2.1.1 Technological advancements in single-cell analysis products 71
5.2.1.2 Rising prevalence of cancer 72
5.2.1.3 Increasing R&D in pharmaceutical and biotechnology industries 73
5.2.1.4 Growth in stem cell research 75
5.2.1.5 Growing focus on personalized medicine 76
5.2.2 RESTRAINTS 77
5.2.2.1 High cost of single-cell analysis products 77
5.2.3 OPPORTUNITIES 78
5.2.3.1 High growth potential of single-cell sequencing 78
5.2.3.2 Integration of microfluidics in single-cell analysis 78
5.2.3.3 Rising potential in emerging Asian markets 79
5.2.4 CHALLENGES 80
5.2.4.1 Lack of standardization in protocols and quality control procedures 80
5.2.4.2 Technical limitations of single-cell analysis 80
5.2.4.3 Mounting ethical and privacy concerns 80
5.3 TECHNOLOGY ANALYSIS 81
5.3.1 KEY TECHNOLOGIES 81
5.3.1.1 Flow cytometry 81
5.3.1.2 Next-generation sequencing 81
5.3.1.3 Polymerase chain reaction 82
5.3.1.4 Microscopy 82
5.3.1.5 Mass spectrometry 83
5.3.2 COMPLEMENTARY TECHNOLOGIES 84
5.3.2.1 Bioinformatics tools and computational analysis 84
5.3.2.2 Multi-omics integration 85
5.3.3 ADJACENT TECHNOLOGIES 85
5.3.3.1 Nanotechnology 85
5.3.3.2 Artificial intelligence and machine learning 85
5.4 SUPPLY CHAIN ANALYSIS 85
5.5 VALUE CHAIN ANALYSIS 87
5.6 PRICING ANALYSIS 88
5.6.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 88
5.6.2 AVERAGE SELLING PRICE OF KEY PLAYERS, BY REGION 89
5.7 ECOSYSTEM ANALYSIS 89
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 92
5.9 PATENT ANALYSIS 92
5.9.1 METHODOLOGY 92
5.9.2 PATENTS APPLIED AND GRANTED, 2014–2025 93
5.10 KEY CONFERENCES AND EVENTS, 2025–2026 95
5.11 REGULATORY LANDSCAPE 96
5.11.1 REGULATORY FRAMEWORK 97
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
5.12 PORTER’S FIVE FORCES ANALYSIS 103
5.12.1 THREAT OF NEW ENTRANTS 104
5.12.2 THREAT OF SUBSTITUTES 104
5.12.3 BARGAINING POWER OF SUPPLIERS 104
5.12.4 BARGAINING POWER OF BUYERS 104
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 105
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 105
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 105
5.13.2 ROLE OF STAKEHOLDERS IN BUYING PROCESS 106
5.13.3 BUYING CRITERIA 106
5.14 INVESTMENT AND FUNDING SCENARIO 108
5.15 TRADE ANALYSIS 109
5.15.1 IMPORT DATA (HS CODE 9027) 109
5.15.2 EXPORT DATA (HS CODE 9027) 111
5.16 IMPACT OF GENERATIVE AI ON SINGLE-CELL ANALYSIS MARKET 112
5.16.1 AI USE CASES 113
5.16.2 KEY COMPANIES IMPLEMENTING AI 114
6 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT 115
6.1 INTRODUCTION 116
6.2 CONSUMABLES 116
6.2.1 BEADS 119
6.2.1.1 Increasing use in research and genetic exploration to drive market 119
6.2.2 MICROPLATES 122
6.2.2.1 Rising frequency of product launches to boost market 122
6.2.3 REAGENTS 125
6.2.3.1 Advancements in single-cell genomics to increase demand 125
6.2.4 ASSAY KITS 128
6.2.4.1 Immunoassays 131
6.2.4.1.1 Growth in geriatric population to fuel demand 131
6.2.4.2 Cell-based assays 133
6.2.4.2.1 Increasing use in pharma and biopharma companies to drive market 133
6.2.5 OTHER CONSUMABLES 136
6.3 INSTRUMENTS 139
6.3.1 FLOW CYTOMETERS 142
6.3.1.1 Technological advancements to drive demand 142
6.3.2 NGS SYSTEMS 146
6.3.2.1 Increased affordability to support segment growth 146
6.3.3 PCR INSTRUMENTS 149
6.3.3.1 Rising use for DNA and mRNA amplification to boost market 149
6.3.4 SPECTROPHOTOMETERS 151
6.3.4.1 Technological advancements to boost market 151
6.3.5 CELL COUNTERS 154
6.3.5.1 Rising demand for automated cell counters to fuel market 154
6.3.6 MICROSCOPES 157
6.3.6.1 Increasing use in cell-based research to drive market 157
6.3.7 HCS SYSTEMS 160
6.3.7.1 Growing need for multi-parametric cell analysis to drive adoption 160
6.3.8 MICROARRAYS 162
6.3.8.1 Increasing development of targeted therapies to support market 162
6.3.9 OTHER INSTRUMENTS 165
7 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE 169
7.1 INTRODUCTION 170
7.2 HUMAN CELLS 170
7.2.1 GROWING FUNDING FOR CANCER RESEARCH TO BOOST DEMAND 170
7.3 ANIMAL CELLS 173
7.3.1 INCREASING ANIMAL CELL RESEARCH TO DRIVE MARKET 173
7.4 MICROBIAL CELLS 176
7.4.1 RISING GOVERNMENT SUPPORT TO COMBAT ANTIMICROBIAL RESISTANCE TO PROPEL MARKET 176
8 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE 180
8.1 INTRODUCTION 181
8.2 FLOW CYTOMETRY 181
8.2.1 INCREASING USE TO IDENTIFY CANCEROUS CELLS TO DRIVE MARKET 181
8.3 NEXT-GENERATION SEQUENCING 185
8.3.1 WIDE ADOPTION IN DRUG DISCOVERY TO DRIVE MARKET 185
8.4 POLYMERASE CHAIN REACTION 188
8.4.1 INCREASING APPLICATIONS OF DIGITAL PCR TO SUPPORT MARKET 188
8.5 MICROSCOPY 191
8.5.1 FOCUS ON DEVELOPMENT OF ADVANCED IMAGING SYSTEMS TO PROPEL MARKET 191
8.6 MASS SPECTROMETRY 194
8.6.1 LAUNCH OF ADVANCED PRODUCTS TO DRIVE MARKET 194
8.7 OTHER TECHNIQUES 197
9 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION 201
9.1 INTRODUCTION 202
9.2 RESEARCH APPLICATIONS 202
9.2.1 CANCER RESEARCH 206
9.2.1.1 Rising prevalence of cancer to drive market 206
9.2.2 IMMUNOLOGY RESEARCH 209
9.2.2.1 High incidence of immunological disorders to propel market 209
9.2.3 NEUROLOGY RESEARCH 212
9.2.3.1 Increasing incidence of neurological disorders to boost market 212
9.2.4 STEM CELL RESEARCH 215
9.2.4.1 Rising investments in stem cell research to drive market 215
9.2.5 OTHER RESEARCH APPLICATIONS 219
9.3 MEDICAL APPLICATIONS 222
9.3.1 NON-INVASIVE PRENATAL DIAGNOSIS 225
9.3.1.1 Increasing prevalence of genetic diseases to drive demand 225
9.3.2 IN VITRO FERTILIZATION 229
9.3.2.1 Growing demand for IVF procedures to support market 229
9.3.3 CIRCULATING TUMOR CELL DETECTION 232
9.3.3.1 Rising prevalence of cancer to contribute to segment growth 232
10 SINGLE-CELL ANALYSIS MARKET, BY END USER 235
10.1 INTRODUCTION 236
10.2 ACADEMIC & RESEARCH LABORATORIES 236
10.2.1 INCREASING FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE MARKET 236
10.3 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES 240
10.3.1 GROWTH IN DRUG DISCOVERY AND R&D ACTIVITIES TO BOOST MARKET 240
10.4 HOSPITALS & DIAGNOSTIC LABORATORIES 243
10.4.1 HIGH PREVALENCE OF INFECTIOUS AND CHRONIC DISEASES TO DRIVE DEMAND 243
10.5 CELL BANKS & IVF CENTERS 247
10.5.1 RISING DEMAND FOR PERSONALIZED AND REGENERATIVE MEDICINE TO PROPEL MARKET 247
11 SINGLE-CELL ANALYSIS MARKET, BY REGION 251
11.1 INTRODUCTION 252
11.2 NORTH AMERICA 252
11.2.1 US 257
11.2.1.1 Increasing R&D investments and funding to drive market 257
11.2.2 CANADA 262
11.2.2.1 High prevalence of hemophilia to propel market 262
11.3 EUROPE 266
11.3.1 GERMANY 270
11.3.1.1 Growing awareness of advanced cell therapies to support market 270
11.3.2 UK 274
11.3.2.1 Growing adoption of single-cell analysis products to drive demand 274
11.3.3 FRANCE 278
11.3.3.1 Growing government funding for R&D to propel market 278
11.3.4 ITALY 282
11.3.4.1 Focus on cell biology research to drive market 282
11.3.5 SPAIN 286
11.3.5.1 Increasing number of biotechnology companies to drive demand 286
11.3.6 REST OF EUROPE 290
11.4 ASIA PACIFIC 295
11.4.1 CHINA 300
11.4.1.1 Increasing R&D expenditure to support market 300
11.4.2 JAPAN 304
11.4.2.1 Increasing geriatric population to fuel demand 304
11.4.3 INDIA 308
11.4.3.1 Growing focus on development of cell-based therapies to boost market 308
11.4.4 SOUTH KOREA 312
11.4.4.1 Increasing number of strategic alliances to boost market 312
11.4.5 AUSTRALIA 316
11.4.5.1 Rising number of life science companies to boost demand 316
11.4.6 REST OF ASIA PACIFIC 320
11.5 LATIN AMERICA 324
11.5.1 BRAZIL 328
11.5.1.1 Rising focus on biotechnology industry to bolster market 328
11.5.2 MEXICO 332
11.5.2.1 Government support for biopharmaceutical production to drive market 332
11.5.3 REST OF LATIN AMERICA 336
11.6 MIDDLE EAST 340
11.6.1 GCC 344
11.6.1.1 Saudi Arabia 348
11.6.1.1.1 Increasing healthcare expenditure to drive market 348
11.6.1.2 United Arab Emirates 352
11.6.1.2.1 Advancements in biopharmaceutical sector to drive demand 352
11.6.1.3 Rest of GCC 356
11.6.2 REST OF MIDDLE EAST 360
11.7 AFRICA 364
11.7.1 GROWING FUNDING FOR DEVELOPMENT AND PRODUCTION OF BIOPHARMACEUTICALS TO DRIVE MARKET 364
12 COMPETITIVE LANDSCAPE 369
12.1 OVERVIEW 369
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025 369
12.3 REVENUE ANALYSIS, 2021–2023 373
12.4 MARKET SHARE ANALYSIS, 2023 374
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 376
12.5.1 STARS 376
12.5.2 EMERGING LEADERS 376
12.5.3 PERVASIVE PLAYERS 376
12.5.4 PARTICIPANTS 376
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 378
12.5.5.1 Company footprint 378
12.5.5.2 Product footprint 379
12.5.5.3 Region footprint 380
12.5.5.4 Technique footprint 381
12.5.5.5 Application footprint 382
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 383
12.6.1 PROGRESSIVE COMPANIES 383
12.6.2 RESPONSIVE COMPANIES 383
12.6.3 DYNAMIC COMPANIES 383
12.6.4 STARTING BLOCKS 383
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 385
12.6.5.1 Detailed list of key startups/SMEs 385
12.6.5.2 Competitive benchmarking of key startups/SMEs 387
12.7 COMPANY VALUATION AND FINANCIAL METRICS 387
12.8 BRAND/PRODUCT COMPARISON 389
12.9 COMPETITIVE SCENARIO 390
12.9.1 PRODUCT LAUNCHES 390
12.9.2 DEALS 391
12.9.3 EXPANSIONS 393
13 COMPANY PROFILES 394
13.1 INTRODUCTION 394
13.2 KEY PLAYERS 394
13.2.1 BD 394
13.2.1.1 Business overview 394
13.2.1.2 Products Offered 395
13.2.1.3 Recent developments 397
13.2.1.3.1 Product launches 397
13.2.1.3.2 Deals 398
13.2.1.4 MnM view 398
13.2.1.4.1 Key strengths 398
13.2.1.4.2 Strategic choices 399
13.2.1.4.3 Weaknesses and competitive threats 399
13.2.2 THERMO FISHER SCIENTIFIC INC. 400
13.2.2.1 Business overview 400
13.2.2.2 Products offered 401
13.2.2.3 Recent developments 404
13.2.2.3.1 Product launches 404
13.2.2.3.2 Deals 404
13.2.2.4 MnM view 405
13.2.3 DANAHER CORPORATION 406
13.2.3.1 Business overview 406
13.2.3.2 Products offered 407
13.2.3.3 Recent developments 409
13.2.3.3.1 Deals 409
13.2.3.4 MnM view 410
13.2.4 10X GENOMICS 411
13.2.4.1 Business overview 411
13.2.4.2 Products offered 412
13.2.4.3 Recent developments 413
13.2.4.3.1 Product launches 413
13.2.4.3.2 Deals 414
13.2.5 MERCK KGAA 416
13.2.5.1 Business overview 416
13.2.5.2 Products offered 417
13.2.5.3 Recent developments 419
13.2.5.3.1 Deals 419
13.2.6 AGILENT TECHNOLOGIES, INC. 420
13.2.6.1 Business overview 420
13.2.6.2 Products offered 421
13.2.6.3 Recent developments 423
13.2.6.3.1 Product launches 423
13.2.6.3.2 Deals 424
13.2.7 QIAGEN 425
13.2.7.1 Business overview 425
13.2.7.2 Products offered 426
13.2.7.3 Recent developments 427
13.2.7.3.1 Deals 427
13.2.8 ILLUMINA, INC. 428
13.2.8.1 Business overview 428
13.2.8.2 Products offered 429
13.2.8.3 Recent developments 431
13.2.8.3.1 Product launches 431
13.2.8.3.2 Deals 431
13.2.9 BIO-RAD LABORATORIES, INC. 433
13.2.9.1 Business overview 433
13.2.9.2 Products offered 434
13.2.9.3 Recent developments 436
13.2.9.3.1 Product launches 436
?
13.2.10 DIASORIN S.P.A. 437
13.2.10.1 Business overview 437
13.2.10.2 Products offered 438
13.2.10.3 Recent developments 439
13.2.10.3.1 Deals 439
13.2.11 STANDARD BIOTOOLS 440
13.2.11.1 Business overview 440
13.2.11.2 Product offered 441
13.2.11.3 Recent developments 442
13.2.11.3.1 Product launches 442
13.2.11.3.2 Deals 442
13.2.12 TECAN TRADING AG 444
13.2.12.1 Business overview 444
13.2.12.2 Products offered 445
13.2.12.3 Recent developments 446
13.2.12.3.1 Product launches 446
13.2.12.3.2 Deals 446
13.2.13 SARTORIUS AG 447
13.2.13.1 Business overview 447
13.2.13.2 Products offered 448
13.2.13.3 Recent developments 449
13.2.13.3.1 Deals 449
13.2.13.3.2 Expansions 449
13.2.14 CORNING INCORPORATED 450
13.2.14.1 Business overview 450
13.2.14.2 Products offered 451
13.2.15 CYTEK BIOSCIENCES 452
13.2.15.1 Business overview 452
13.2.15.2 Products offered 453
13.2.15.3 Recent developments 453
13.2.15.3.1 Deals 453
13.2.15.3.2 Expansions 454
13.2.16 TAKARA BIO INC. 455
13.2.16.1 Business overview 455
13.2.16.2 Products offered 456
13.2.16.3 Recent developments 458
13.2.17 BIOM?RIEUX 459
13.2.17.1 Business overview 459
13.2.17.2 Products offered 460
13.2.17.3 Recent developments 461
?
13.2.18 REVVITY 462
13.2.18.1 Business overview 462
13.2.18.2 Products offered 463
13.2.18.3 Recent developments 465
13.2.19 BIO-TECHNE 466
13.2.19.1 Business overview 466
13.2.19.2 Products offered 467
13.2.19.3 Recent developments 468
13.2.20 PACBIO 469
13.2.20.1 Business overview 469
13.2.20.2 Products offered 470
13.2.20.3 Recent developments 470
13.2.21 BRUKER 471
13.2.21.1 Business overview 471
13.2.21.2 Products offered 473
13.2.21.3 Recent developments 473
13.2.22 PROMEGA CORPORATION 475
13.2.22.1 Business overview 475
13.2.22.2 Products offered 475
13.2.23 OXFORD NANOPORE TECHNOLOGIES PLC 477
13.2.23.1 Business overview 477
13.2.23.2 Products offered 478
13.3 OTHER PLAYERS 479
13.3.1 SINGLERON BIOTECHNOLOGIES 479
13.3.2 CELL MICROSYSTEMS 480
13.3.3 NANOCELLECT BIOMEDICAL 481
13.3.4 RARECYTE, INC. 482
13.3.5 BICO 483
13.3.6 MENARINI GROUP 484
14 DISCUSSION GUIDE 485
14.1 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 491
14.2 CUSTOMIZATION OPTIONS 493
14.3 RELATED REPORTS 493
14.4 AUTHOR DETAILS 494



List of Figures

FIGURE 1 SINGLE-CELL ANALYSIS MARKET: RESEARCH DESIGN 50
FIGURE 2 BREAKDOWN OF PRIMARIES: SINGLE-CELL ANALYSIS MARKET 52
FIGURE 3 SINGLE-CELL ANALYSIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 53
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023 54
FIGURE 5 ILLUSTRATIVE EXAMPLE OF BD COMPANY: REVENUE ANALYSIS, 2023 54
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 56
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 56
FIGURE 8 SINGLE-CELL ANALYSIS MARKET: CAGR PROJECTIONS 58
FIGURE 9 DATA TRIANGULATION METHODOLOGY 60
FIGURE 10 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 62
FIGURE 11 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2024 VS. 2029 (USD MILLION) 63
FIGURE 12 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION) 63
FIGURE 13 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 64
FIGURE 14 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 64
FIGURE 15 GEOGRAPHIC SNAPSHOT OF SINGLE-CELL ANALYSIS MARKET 65
FIGURE 16 GROWTH IN STEM CELL RESEARCH TO DRIVE MARKET 66
FIGURE 17 HUMAN CELLS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SINGLE-CELL ANALYSIS MARKET IN 2023 67
FIGURE 18 CONSUMABLES SEGMENT ACCOUNTED FOR LARGER MARKET SHARE IN 2023 67
FIGURE 19 ACADEMIC & RESEARCH LABORATORIES SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD 68
FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 68
FIGURE 21 SINGLE-CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES 69
FIGURE 22 AGE-STANDARDIZED RATE (WORLD) PER 100,000 CANCER INCIDENCES IN BOTH SEXES, 2022 73
FIGURE 23 WORLDWIDE TOTAL PHARMACEUTICAL R&D SPEND, 2014–2028 74
FIGURE 24 SHARE OF PERSONALIZED MEDICINE IN FDA’S NEW DRUG APPROVALS FOR LAST NINE YEARS 77
FIGURE 25 SINGLE-CELL ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS 86
FIGURE 26 SINGLE-CELL ANALYSIS MARKET: VALUE CHAIN ANALYSIS 87
FIGURE 27 SINGLE-CELL ANALYSIS MARKET: ECOSYSTEM ANALYSIS 89
FIGURE 28 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 92
FIGURE 29 PATENT APPLICATIONS IN SINGLE-CELL ANALYSIS MARKET JANUARY 2014–JUNE 2024 93
FIGURE 30 SINGLE-CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 103
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-CELL ANALYSIS PRODUCTS 105
FIGURE 32 KEY BUYING CRITERIA FOR END USERS 106
FIGURE 33 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, 2022–2029 (THOUSAND UNITS) 143
FIGURE 34 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET SNAPSHOT 253
FIGURE 35 NIH FUNDING FOR STEM CELL RESEARCH, 2015–2025 258
FIGURE 36 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET SNAPSHOT 296
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE-CELL ANALYSIS
MARKET, 2021–2023 373
FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023 374
FIGURE 39 SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2023 377
FIGURE 40 SINGLE-CELL ANALYSIS MARKET: COMPANY FOOTPRINT 378
FIGURE 41 SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX, (STARTUPS/SMES), 2023 384
FIGURE 42 EV/EBITDA OF KEY VENDORS 387
FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS 388
FIGURE 44 SINGLE-CELL ANALYSIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 389
FIGURE 45 BD: COMPANY SNAPSHOT (2024) 395
FIGURE 46 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023) 401
FIGURE 47 DANAHER CORPORATION: COMPANY SNAPSHOT (2023) 407
FIGURE 48 10X GENOMICS: COMPANY SNAPSHOT 412
FIGURE 49 MERCK KGAA: COMPANY SNAPSHOT (2023) 417
FIGURE 50 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024) 421
FIGURE 51 QIAGEN: COMPANY SNAPSHOT (2023) 426
FIGURE 52 ILLUMINA, INC.: COMPANY SNAPSHOT 429
FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023) 434
FIGURE 54 DIASORIN S.P.A.: COMPANY SNAPSHOT (2023) 438
FIGURE 55 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2023) 441
FIGURE 56 TECAN TRADING AG: COMPANY SNAPSHOT (2023) 445
FIGURE 57 SARTORIUS AG: COMPANY SNAPSHOT (2023) 448
FIGURE 58 CORNING INCORPORATED: COMPANY SNAPSHOT (2023) 451
FIGURE 59 CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2023) 452
FIGURE 60 TAKARA BIO INC.: COMPANY SNAPSHOT 456

List of Tables

TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 58
TABLE 2 SINGLE-CELL ANALYSIS MARKET: IMPACT ANALYSIS 70
TABLE 3 RECENT TECHNOLOGICAL ADVANCEMENTS AND PRODUCT LAUNCHES 71
TABLE 4 PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2020 VS. 2035 72
TABLE 5 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2020 VS. 2026 (USD BILLION) 74
TABLE 6 ESTIMATED EXPENDITURE BY NIH FOR STEM CELL RESEARCH, 2019–2025 76
TABLE 7 APPLICATIONS OF MICROSCOPIC TECHNIQUES IN SINGLE-CELL ANALYSIS 82
TABLE 8 TYPES OF BIOINFORMATICS TOOLS 84
TABLE 9 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2021–2023 88
TABLE 10 AVERAGE SELLING PRICE OF KEY PLAYERS, BY REGION, 2023 89
TABLE 11 SINGLE-CELL ANALYSIS MARKET: RAW MATERIAL VENDORS 90
TABLE 12 SINGLE-CELL ANALYSIS MARKET: PRODUCT VENDORS 90
TABLE 13 SINGLE-CELL ANALYSIS MARKET: END USERS 91
TABLE 14 SINGLE-CELL ANALYSIS MARKET: REGULATORY BODIES 91
TABLE 15 PATENTS FILED, 2014–2025 93
TABLE 16 INNOVATIONS AND PATENT REGISTRATIONS, 2023–2024 94
TABLE 17 SINGLE-CELL ANALYSIS MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 95
TABLE 18 SINGLE-CELL ANALYSIS MARKET: REGULATORY GUIDELINES 97
TABLE 19 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
TABLE 20 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
TABLE 21 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 22 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
TABLE 23 SINGLE-CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 104
TABLE 24 BUYING CRITERIA FOR SINGLE-CELL ANALYSIS PRODUCTS, BY END USER 107
TABLE 25 IMPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2019–2023 (USD THOUSAND) 109
TABLE 26 IMPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2019–2023 (TONS) 110
TABLE 27 EXPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2019–2023 (USD THOUSAND) 111
TABLE 28 EXPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2019–2023 (TONS) 112
TABLE 29 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 116
TABLE 30 SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE 2022–2029 (USD MILLION) 116
TABLE 31 SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY REGION 2022–2029 (USD MILLION) 117
TABLE 32 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 33 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 34 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 118
TABLE 35 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES BY COUNTRY, 2022–2029 (USD MILLION) 118
TABLE 36 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES BY COUNTRY, 2022–2029 (USD MILLION) 118
TABLE 37 GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY 2022–2029 (USD MILLION) 119
TABLE 38 SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY REGION 2022–2029 (USD MILLION) 120
TABLE 39 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2022–2029 (USD MILLION) 120
TABLE 40 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY 2022–2029 (USD MILLION) 120
TABLE 41 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY 2022–2029 (USD MILLION) 121
TABLE 42 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2022–2029 (USD MILLION) 121
TABLE 43 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY 2022–2029 (USD MILLION) 121
TABLE 44 GCC: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY 2022–2029 (USD MILLION) 122
TABLE 45 SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY REGION 2022–2029 (USD MILLION) 123
TABLE 46 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 47 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 48 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 49 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 50 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 51 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY 2022–2029 (USD MILLION) 125
TABLE 52 SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY REGION 2022–2029 (USD MILLION) 125
TABLE 53 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 54 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY 2022–2029 (USD MILLION) 126
TABLE 55 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 56 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS BY COUNTRY, 2022–2029 (USD MILLION) 127
TABLE 57 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS BY COUNTRY, 2022–2029 (USD MILLION) 127
TABLE 58 GCC: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY 2022–2029 (USD MILLION) 127
TABLE 59 SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE 2022–2029 (USD MILLION) 128
TABLE 60 SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY REGION 2022–2029 (USD MILLION) 128
TABLE 61 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 62 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY 2022–2029 (USD MILLION) 129
TABLE 63 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 64 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION) 130
TABLE 65 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION) 130
TABLE 66 GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY 2022–2029 (USD MILLION) 130
TABLE 67 SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY REGION, 2022–2029 (USD MILLION) 131
TABLE 68 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 69 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 70 ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 71 LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 72 MIDDLE EAST: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 73 GCC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 74 SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS BY REGION, 2022–2029 (USD MILLION) 134
TABLE 75 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 76 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 77 ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 78 LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 79 MIDDLE EAST: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 80 GCC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 81 SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY REGION 2022–2029 (USD MILLION) 136
TABLE 82 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 83 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 84 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 85 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 86 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 87 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 88 SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE 2022–2029 (USD MILLION) 139
TABLE 89 SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY REGION 2022–2029 (USD MILLION) 140
TABLE 90 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 91 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 92 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 93 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 94 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 95 GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY 2022–2029 (USD MILLION) 142
TABLE 96 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY REGION 2022–2029 (USD MILLION) 143
TABLE 97 NORTH AMERICA: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 98 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 99 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 100 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 101 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 102 GCC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 103 SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY REGION 2022–2029 (USD MILLION) 146
TABLE 104 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS BY COUNTRY, 2022–2029 (USD MILLION) 147
TABLE 105 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 147
TABLE 106 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 147
TABLE 107 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 108 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 109 GCC: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY 2022–2029 (USD MILLION) 148
TABLE 110 SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY REGION 2022–2029 (USD MILLION) 149
TABLE 111 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 112 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 113 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 114 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 115 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS BY COUNTRY, 2022–2029 (USD MILLION) 151
TABLE 116 GCC: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 151
TABLE 117 SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY REGION, 2022–2029 (USD MILLION) 152
TABLE 118 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 119 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 120 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 121 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 122 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 123 GCC: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2022–2029 (USD MILLION) 154
TABLE 124 SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY REGION 2022–2029 (USD MILLION) 155
TABLE 125 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 126 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 127 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 128 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 129 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 130 GCC: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY 2022–2029 (USD MILLION) 157
TABLE 131 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY REGION 2022–2029 (USD MILLION) 157
TABLE 132 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 133 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 134 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 135 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES BY COUNTRY, 2022–2029 (USD MILLION) 159
TABLE 136 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES BY COUNTRY, 2022–2029 (USD MILLION) 159
TABLE 137 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY 2022–2029 (USD MILLION) 159
TABLE 138 SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY REGION 2022–2029 (USD MILLION) 160
TABLE 139 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS BY COUNTRY, 2022–2029 (USD MILLION) 160
TABLE 140 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 141 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 142 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 143 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS BY COUNTRY, 2022–2029 (USD MILLION) 162
TABLE 144 GCC: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY 2022–2029 (USD MILLION) 162
TABLE 145 SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY REGION 2022–2029 (USD MILLION) 163
TABLE 146 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS BY COUNTRY, 2022–2029 (USD MILLION) 163
TABLE 147 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 148 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 149 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 150 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS BY COUNTRY, 2022–2029 (USD MILLION) 165
TABLE 151 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY 2022–2029 (USD MILLION) 165
TABLE 152 SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION 2022–2029 (USD MILLION) 166
TABLE 153 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS BY COUNTRY, 2022–2029 (USD MILLION) 166
TABLE 154 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS BY COUNTRY, 2022–2029 (USD MILLION) 166
TABLE 155 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 156 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 157 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 158 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 159 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 170
TABLE 160 SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY REGION 2022–2029 (USD MILLION) 171
TABLE 161 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS BY COUNTRY, 2022–2029 (USD MILLION) 171
TABLE 162 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 172
TABLE 163 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 172
TABLE 164 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS BY COUNTRY, 2022–2029 (USD MILLION) 172
TABLE 165 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 166 GCC: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY 2022–2029 (USD MILLION) 173
TABLE 167 SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY REGION 2022–2029 (USD MILLION) 174
TABLE 168 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 169 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 175
TABLE 170 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 175
TABLE 171 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS BY COUNTRY, 2022–2029 (USD MILLION) 175
TABLE 172 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS BY COUNTRY, 2022–2029 (USD MILLION) 176
TABLE 173 GCC: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY 2022–2029 (USD MILLION) 176
TABLE 174 SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY REGION 2022–2029 (USD MILLION) 177
TABLE 175 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 176 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 178
TABLE 177 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS BY COUNTRY, 2022–2029 (USD MILLION) 178
TABLE 178 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS BY COUNTRY, 2022–2029 (USD MILLION) 178
TABLE 179 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS BY COUNTRY, 2022–2029 (USD MILLION) 179
TABLE 180 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 179
TABLE 181 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 181
TABLE 182 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION 2022–2029 (USD MILLION) 182
TABLE 183 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY BY COUNTRY, 2022–2029 (USD MILLION) 182
TABLE 184 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022–2029 (USD MILLION) 183
TABLE 185 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY BY COUNTRY, 2022–2029 (USD MILLION) 183
TABLE 186 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY BY COUNTRY, 2022–2029 (USD MILLION) 184
TABLE 187 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY BY COUNTRY, 2022–2029 (USD MILLION) 184
TABLE 188 GCC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022–2029 (USD MILLION) 184
TABLE 189 SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING BY REGION, 2022–2029 (USD MILLION) 185
TABLE 190 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION) 186
TABLE 191 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION) 186
TABLE 192 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION) 187
TABLE 193 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION) 187
TABLE 194 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION) 187
TABLE 195 GCC: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING BY COUNTRY, 2022–2029 (USD MILLION) 188
TABLE 196 SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2022–2029 (USD MILLION) 189
TABLE 197 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2022–2029 (USD MILLION) 189
TABLE 198 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION BY COUNTRY, 2022–2029 (USD MILLION) 189
TABLE 199 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2022–2029 (USD MILLION) 190
TABLE 200 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2022–2029 (USD MILLION) 190
TABLE 201 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2022–2029 (USD MILLION) 190
TABLE 202 GCC: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION BY COUNTRY, 2022–2029 (USD MILLION) 191
TABLE 203 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY REGION 2022–2029 (USD MILLION) 191
TABLE 204 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY BY COUNTRY, 2022–2029 (USD MILLION) 192
TABLE 205 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION) 192
TABLE 206 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION) 192
TABLE 207 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION) 193
TABLE 208 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION) 193
TABLE 209 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY 2022–2029 (USD MILLION) 193
TABLE 210 SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY REGION 2022–2029 (USD MILLION) 194
TABLE 211 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY BY COUNTRY, 2022–2029 (USD MILLION) 194
TABLE 212 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY BY COUNTRY, 2022–2029 (USD MILLION) 195
TABLE 213 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY BY COUNTRY, 2022–2029 (USD MILLION) 195
TABLE 214 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY BY COUNTRY, 2022–2029 (USD MILLION) 196
TABLE 215 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY BY COUNTRY, 2022–2029 (USD MILLION) 196
TABLE 216 GCC: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY BY COUNTRY, 2022–2029 (USD MILLION) 196
TABLE 217 SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY REGION 2022–2029 (USD MILLION) 198
TABLE 218 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES BY COUNTRY, 2022–2029 (USD MILLION) 198
TABLE 219 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 198
TABLE 220 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES BY COUNTRY, 2022–2029 (USD MILLION) 199
TABLE 221 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES BY COUNTRY, 2022–2029 (USD MILLION) 199
TABLE 222 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES BY COUNTRY, 2022–2029 (USD MILLION) 200
TABLE 223 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 200
TABLE 224 SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 202
TABLE 225 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE 2022–2029 (USD MILLION) 203
TABLE 226 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 203
TABLE 227 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 203
TABLE 228 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS BY COUNTRY, 2022–2029 (USD MILLION) 204
TABLE 229 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS BY COUNTRY, 2022–2029 (USD MILLION) 204
TABLE 230 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 231 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 232 GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 233 SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY REGION 2022–2029 (USD MILLION) 206
TABLE 234 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH BY COUNTRY, 2022–2029 (USD MILLION) 206
TABLE 235 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION) 207
TABLE 236 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH BY COUNTRY, 2022–2029 (USD MILLION) 207
TABLE 237 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH BY COUNTRY, 2022–2029 (USD MILLION) 208
TABLE 238 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH BY COUNTRY, 2022–2029 (USD MILLION) 208
TABLE 239 GCC: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION) 208
TABLE 240 SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY REGION, 2022–2029 (USD MILLION) 209
TABLE 241 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION) 210
TABLE 242 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH BY COUNTRY, 2022–2029 (USD MILLION) 210
TABLE 243 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH BY COUNTRY, 2022–2029 (USD MILLION) 211
TABLE 244 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION) 211
TABLE 245 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH BY COUNTRY, 2022–2029 (USD MILLION) 211
TABLE 246 GCC: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH BY COUNTRY, 2022–2029 (USD MILLION) 212
TABLE 247 SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY REGION 2022–2029 (USD MILLION) 213
TABLE 248 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION) 213
TABLE 249 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH BY COUNTRY, 2022–2029 (USD MILLION) 213
TABLE 250 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH BY COUNTRY, 2022–2029 (USD MILLION) 214
TABLE 251 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH BY COUNTRY, 2022–2029 (USD MILLION) 214
TABLE 252 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH BY COUNTRY, 2022–2029 (USD MILLION) 214
TABLE 253 GCC: SINGLE-CELL ANALYSIS